Surveillance of Hepatocellular Cancer Among Hepatitis B and Cirrhosis Patients Using Protein Induced by Vitamin K Absence-II (PIVKA-II): A Cost-Utility Analysis for Hong Kong as an Example of Endemic Regions

Home / Key Publications / Health Economics / Surveillance of Hepatocellular Cancer Among Hepatitis B and Cirrhosis Patients Using Protein Induced by Vitamin K Absence-II (PIVKA-II): A Cost-Utility Analysis for Hong Kong as an Example of Endemic Regions

You May Also Like

Prof Chan Wah Keong

12 February 2026

LEAD Perspective: Evaluating GAAD – A Malaysian Multicentre Study

12 February 2026

LEAD Perspective: The Taiwan Liver Story – Hepatitis Elimination and HCC Surveillance

12 February 2026

LEAD Perspective: Asia Pacific Consensus Statement on the clinical and economic utility of biomarker-based algorithms in the early detection and surveillance of HCC

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.